Yes, alopecia areata is an autoimmune disorder. It occurs when the immune system mistakenly attacks hair follicles, causing hair to fall out in patches or, in severe cases, across the entire body. It affects about 2% of the global population, with a lifetime risk between 1.7% and 2.1%. While other forms of hair loss exist (pattern baldness, stress-related shedding), alopecia areata is distinct because the immune system is the direct cause.
How the Immune System Attacks Hair Follicles
In alopecia areata, a specific type of white blood cell called a CD8+ T cell infiltrates the skin around hair follicles. These cells are part of the body’s normal defense against infections and abnormal cells, but in this condition they treat healthy hair follicles as threats. Recent single-cell genetic sequencing has confirmed that these aren’t random immune cells wandering into the wrong neighborhood. They’re clonally expanded populations, meaning the body produced large numbers of identical copies of specific T cells programmed to target hair follicles.
This distinction matters because it confirms alopecia areata isn’t just general inflammation that happens to affect hair. Research published in Cell Reports demonstrated that transplanting the specific T cell receptors from these expanded clones into mice was enough to trigger the disease on its own. When researchers depleted those same T cell populations, the disease was prevented or reduced. This is strong evidence of a direct causal relationship between these immune cells and hair loss.
What Triggers It
The underlying vulnerability is genetic. Many of the genes linked to alopecia areata belong to the HLA complex, a group of genes that help the immune system distinguish the body’s own cells from foreign invaders. Variations in these genes can make the immune system more likely to misidentify hair follicles as targets. Researchers have also identified genes involved in inflammation and immune signaling that increase susceptibility.
But genetics alone don’t explain why the condition appears when it does. Psychological stress is one of the most commonly reported triggers. Among children with alopecia areata, school-related events were the most frequently identified stressors in case-control studies. Stress activates inflammatory pathways that can push a genetically primed immune system over the edge into active disease. Viral infections and other immune challenges have also been linked to flares, though the evidence for stress is the most consistent.
Not All Hair Loss Is Autoimmune
Alopecia is a broad term that simply means hair loss, and most types are not autoimmune. Androgenetic alopecia (pattern baldness) is driven by hormones and genetics. Telogen effluvium is diffuse shedding triggered by stress, illness, or hormonal shifts. Traction alopecia comes from hairstyles that pull on hair. None of these involve the immune system attacking follicles.
Among immune-mediated hair loss conditions, there are two main categories. Non-scarring types, like alopecia areata, leave the follicle structure intact, which means regrowth is possible. Scarring types, like lichen planopilaris and frontal fibrosing alopecia, involve immune-driven inflammation that permanently destroys follicles. The distinction between scarring and non-scarring is one of the first things a dermatologist assesses because it determines whether regrowth is realistic.
How It’s Diagnosed
Most cases are diagnosed clinically based on the characteristic pattern of smooth, round patches of hair loss. When the presentation is less clear, a scalp biopsy can confirm the diagnosis. The hallmark finding under a microscope is a cluster of immune cells surrounding the base of hair follicles, known as a peribulbar lymphocytic infiltrate, present in about 84% of biopsy specimens. Pathologists also look for miniaturized follicles (seen in 90% of cases) and follicles stuck in a resting or transitional phase (93% of cases). These secondary features are especially useful when the immune cell clustering isn’t obvious in the tissue sample.
Linked Autoimmune Conditions
Having alopecia areata roughly doubles your risk of developing another autoimmune or immune-mediated condition. About 16% of people with alopecia areata have at least one additional autoimmune disease, compared to 9% of the general population. The conditions most strongly associated with it include lupus (nearly six times the risk of the general population), atopic dermatitis (about four times the risk), and vitiligo (nearly four times the risk). Thyroid disease, psoriasis, and rheumatoid arthritis also show up at higher rates.
This clustering isn’t surprising given the shared genetic pathways. The same HLA gene variations that predispose someone to alopecia areata overlap with those linked to other autoimmune conditions. If you’ve been diagnosed with alopecia areata, your doctor may periodically screen for thyroid problems or other related conditions, particularly if new symptoms develop.
Treatment Options
For limited, patchy hair loss, the typical first approach is corticosteroid injections into the affected areas or strong topical corticosteroids applied to the scalp. These work by calming the local immune response enough to let follicles resume producing hair.
For more extensive hair loss, a class of medications called JAK inhibitors has transformed treatment in recent years. Three are now FDA-approved specifically for alopecia areata: baricitinib, ritlecitinib, and deuruxolitinib. These drugs work by blocking the signaling pathways that activate the rogue T cells responsible for attacking follicles.
The results vary by timeframe. In clinical trials, roughly one-third of patients taking baricitinib or deuruxolitinib achieved 80% or greater scalp hair coverage within about six to nine months. The longer-term data is more encouraging: after two years of continuous baricitinib treatment, 90% of patients reached that same 80% regrowth threshold. These medications are taken as daily pills, not injections or topical treatments, which makes them more practical for widespread hair loss.
For cases that don’t respond to these options, alternatives include topical immunotherapy (which works by creating a controlled allergic reaction on the scalp to redirect the immune system), other JAK inhibitors, or oral immunosuppressants. Because the underlying autoimmune process can return, many people need ongoing treatment to maintain regrowth. Stopping medication often leads to new episodes of hair loss, though the severity and timing are unpredictable.